ABB is a leading technology company. Its products and services can be used in automated manufacturing, providing digital solutions, electrification of industry and transport and enhancing productivity. It reports business under 4 segments - Electrification, Robotics & Discrete Automation, Process Automation and Motion. Electrification segment is responsible for the manufacture and sale of products and services, including low and medium voltage switchgear, control products, DIN rail components, wiring accessories and installation material for a plethora of applications. Robotics & Discrete Automation: This segment includes the machine and factory automation solutions from the business of B&R and a wide-ranging robotics solutions and applications suite. Process Automation: This provides control and plant optimization systems and automation products and solutions for optimizing the productivity of industrial processes. Motion:'The segment specializes in supplying motors, drives and generator products....
+See MoreSharpe-Lintner-Black CAPM alpha (Premium Members Only) Fama-French (1993) 3-factor alpha (Premium Members Only) Fama-French-Carhart 4-factor alpha (Premium Members Only) Fama-French (2015) 5-factor alpha (Premium Members Only) Fama-French-Carhart 6-factor alpha (Premium Members Only) Dynamic conditional 6-factor alpha (Premium Members Only) Last update: Saturday 12 September 2026
2022-05-30 09:32:00 Monday ET

The new semiconductor microchip demand-supply imbalance remains quite severe for the U.S. tech and auto industries. Our current fundamental macro a
2018-01-10 08:40:00 Wednesday ET

President Trump considers imposing retaliatory economic sanctions on Chinese products and services in direct response to China's theft and infringement
2017-10-09 09:34:00 Monday ET

The current Trump stock market rally has been impressive from November 2016 to October 2017. S&P 500 has risen by 21.1% since the 2016 presidential elec
2019-01-10 17:31:00 Thursday ET

The recent Bristol-Myers Squibb acquisition of American Celgene is the $90 billion biggest biotech deal in history. The resultant biopharma goliath would be
2018-10-05 10:38:00 Friday ET

A 7-year $1.3 billion hedge fund manager Chelsea Brennan shares her investment advice. Her advice encompasses several steps toward better financial literacy
2023-05-31 03:15:40 Wednesday ET

The U.S. further derisks and decouples from China. Why does the U.S. seek to further economically decouple from China? In recent times, th